BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9874851)

  • 1. Neurofibromatosis 1 in childhood.
    North KN
    Semin Pediatr Neurol; 1998 Dec; 5(4):231-42. PubMed ID: 9874851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
    Karwacki MW; Woźniak W
    Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical diagnosis of neurofibromatosis type 1].
    Wolkenstein P; Zeller J
    Presse Med; 1999 Dec; 28(39):2174-80. PubMed ID: 10629698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromas in children with neurofibromatosis 1.
    Rosser T; Packer RJ
    J Child Neurol; 2002 Aug; 17(8):585-91; discussion 602-4, 646-51. PubMed ID: 12403557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of neurofibromatosis 1.
    North KN
    Eur J Paediatr Neurol; 1998; 2(5):223-31. PubMed ID: 10726824
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis and the most frequent symptoms of neurofibromatosis type 1].
    Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
    Klin Oczna; 2009; 111(10-12):378-83. PubMed ID: 20169901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
    Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
    Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unusual clinical manifestations of type 1 neurofibromatosis].
    Komlósi K; Polgár N; Hadzsiev K; Ottóffy G; Illés T; Dóczi T; Melegh B
    Orv Hetil; 2011 Dec; 152(49):1965-70. PubMed ID: 22106164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis.
    Roos KL; Muckway M
    Dermatol Clin; 1995 Jan; 13(1):105-11. PubMed ID: 7712636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients.
    Ars E; Kruyer H; Morell M; Pros E; Serra E; Ravella A; Estivill X; Lázaro C
    J Med Genet; 2003 Jun; 40(6):e82. PubMed ID: 12807981
    [No Abstract]   [Full Text] [Related]  

  • 15. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
    Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
    Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
    Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
    An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
    Trovó-Marqui AB; Goloni-Bertollo EM; Valério NI; Pavarino-Bertelli EC; Muniz MP; Teixeira MF; Antonio JR; Tajara EH
    Braz J Med Biol Res; 2005 Sep; 38(9):1441-7. PubMed ID: 16138229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
    Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
    Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.